265 related articles for article (PubMed ID: 37338346)
1. Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria.
Sui B; Wang X; Zhao T; Zhen J; Ren H; Liu W; Zhang X; Zhang C
Appl Environ Microbiol; 2023 Jul; 89(7):e0058123. PubMed ID: 37338346
[TBL] [Abstract][Full Text] [Related]
2. Multiple-site mutations of phage Bp7 endolysin improves its activities against target bacteria.
Zhang C; Wang Y; Sun H; Ren H
Virol Sin; 2015 Oct; 30(5):386-95. PubMed ID: 26490045
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria.
Zhang S; Chang Y; Zhang Q; Yuan Y; Qi Q; Lu X
Microb Cell Fact; 2022 Aug; 21(1):171. PubMed ID: 35999567
[TBL] [Abstract][Full Text] [Related]
4. Endolysins of bacteriophage vB_Sal-S-S10 can naturally lyse Salmonella enteritidis.
Wang X; Han L; Rong J; Ren H; Liu W; Zhang C
BMC Vet Res; 2022 Nov; 18(1):410. PubMed ID: 36411417
[TBL] [Abstract][Full Text] [Related]
5. Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria.
Zampara A; Sørensen MCH; Grimon D; Antenucci F; Vitt AR; Bortolaia V; Briers Y; Brøndsted L
Sci Rep; 2020 Jul; 10(1):12087. PubMed ID: 32694655
[TBL] [Abstract][Full Text] [Related]
6. Unveiling the mechanism of bactericidal activity of a cecropin A-fused endolysin LNT113.
Cho J; Hong HW; Park K; Myung H; Yoon H
Int J Biol Macromol; 2024 Mar; 260(Pt 1):129493. PubMed ID: 38224804
[TBL] [Abstract][Full Text] [Related]
7. Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1.
Walmagh M; Briers Y; dos Santos SB; Azeredo J; Lavigne R
PLoS One; 2012; 7(5):e36991. PubMed ID: 22615864
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Three Different Endolysins Effective against Gram-Negative Bacteria.
Jeong TH; Hong HW; Kim MS; Song M; Myung H
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992387
[TBL] [Abstract][Full Text] [Related]
9. Gram-negative endolysins: overcoming the outer membrane obstacle.
Sisson HM; Jackson SA; Fagerlund RD; Warring SL; Fineran PC
Curr Opin Microbiol; 2024 Apr; 78():102433. PubMed ID: 38350268
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of SAR-endolysin LysKpV475 with polymyxin B and
Gontijo M; Pereira Teles M; Martins Correia H; Pérez Jorge G; Rodrigues Santos Goes IC; Fasabi Flores AJ; Braz M; de Moraes Ceseti L; Zonzini Ramos P; Rosa E Silva I; Pereira Vidigal PM; Kobarg J; Miguez Couñago R; Alvarez-Martinez CE; Pereira C; Freire CSR; Almeida A; Brocchi M
Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38739436
[TBL] [Abstract][Full Text] [Related]
11. Characterization of five novel endolysins from Gram-negative infecting bacteriophages.
Walmagh M; Boczkowska B; Grymonprez B; Briers Y; Drulis-Kawa Z; Lavigne R
Appl Microbiol Biotechnol; 2013 May; 97(10):4369-75. PubMed ID: 22832988
[TBL] [Abstract][Full Text] [Related]
12. 'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci.
Rodríguez-Rubio L; Chang WL; Gutiérrez D; Lavigne R; Martínez B; Rodríguez A; Govers SK; Aertsen A; Hirl C; Biebl M; Briers Y; García P
Sci Rep; 2016 Oct; 6():35382. PubMed ID: 27775093
[TBL] [Abstract][Full Text] [Related]
13. Bacteriophage endolysins as a novel class of antibacterial agents.
Borysowski J; Weber-Dabrowska B; Górski A
Exp Biol Med (Maywood); 2006 Apr; 231(4):366-77. PubMed ID: 16565432
[TBL] [Abstract][Full Text] [Related]
14. Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.
Briers Y; Lavigne R
Future Microbiol; 2015; 10(3):377-90. PubMed ID: 25812461
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial synergy between a phage endolysin and citric acid against the Gram-negative kiwifruit pathogen
Sisson HM; Fagerlund RD; Jackson SA; Briers Y; Warring SL; Fineran PC
Appl Environ Microbiol; 2024 Mar; 90(3):e0184623. PubMed ID: 38319087
[TBL] [Abstract][Full Text] [Related]
16. Peptidoglycan degrading activity of the broad-range Salmonella bacteriophage S-394 recombinant endolysin.
Legotsky SA; Vlasova KY; Priyma AD; Shneider MM; Pugachev VG; Totmenina OD; Kabanov AV; Miroshnikov KA; Klyachko NL
Biochimie; 2014 Dec; 107 Pt B():293-9. PubMed ID: 25241254
[TBL] [Abstract][Full Text] [Related]
17. The structure and function of modular Escherichia coli O157:H7 bacteriophage FTBEc1 endolysin, LysT84: defining a new endolysin catalytic subfamily.
Love MJ; Coombes D; Ismail S; Billington C; Dobson RCJ
Biochem J; 2022 Jan; 479(2):207-223. PubMed ID: 34935873
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens.
Lim J; Hong J; Jung Y; Ha J; Kim H; Myung H; Song M
J Microbiol Biotechnol; 2022 Jun; 32(6):816-823. PubMed ID: 35586934
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the engineered endolysin mtEC340M.
Wang JM; Seok SH; Yoon WS; Kim JH; Seo MD
Acta Crystallogr F Struct Biol Commun; 2023 May; 79(Pt 5):105-110. PubMed ID: 37132476
[TBL] [Abstract][Full Text] [Related]
20. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant
Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R
Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
